Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-24 @ 11:43 PM
NCT ID:
NCT03239951
Eligibility Criteria:
Inclusion Criteria:
* Male with AUR secondary to BPO
* Age ≥40 years
* Acute urinary retention with at least one failed trial without catheter (TWOC) while on alpha blocker
* Ability to sign an informed consent form
* Prostate volume \<80 ml
* Life expectancy \>1 year.
Exclusion Criteria:
* Suspected malignant disease of the lower urinary tract including prostate or bladder cancer
* Chronic retention of urine with history of either retention volume greater than one liter or upper tract obstruction
* Known neurogenic bladder
* Immunosuppression
* Suspected urethral strictures, bladder neck contracture, Urinary bladder stones
* An obstructive or protruding median lobe of the prostate
* An active symptomatic urinary tract infection
* Enrolled in another treatment trial for any disease
* Previous pelvic irradiation or radical pelvic surgery
* Any previous prostate surgery.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
40 Years
Maximum Age:
90 Years
Study:
NCT03239951
Study Brief:
Protocol Section:
NCT03239951